Increased treatment response and bone density in patients with chronic hepatitis b switched to tenofovir alafenamide from other nucleos(t) ide analogue: 96-week results from a prospective multinational studyEiichi Ogawa,Dae Won Jun,Hidenori Toyoda,Yao-Chun Hsu,Eileen Yoon,Sang Bong Ahn,Son T. Do,Huy N. Trinh,Hirokazu Takahashi,Masaru Enomoto, Norifumi Kawada,Satoshi Yasuda,Cheng-Hao Tseng,Ming-Lun Yeh,Keigo Kawashima,Han Ah Lee,Kaori Inoue,Hiroaki Haga,Ai-Thien Do,Mayumi Maeda,Joseph Hoang,Ramsey Cheung,Yoshiyuki Ueno, Yuichiro Eguchi,Norihiro Furusyo,Ming-Lung Yu,Yasuhito Tanaka,Mindie H. NguyenJOURNAL OF HEPATOLOGY（2022）引用 0|浏览15暂无评分关键词tenofovir alafenamide,bone density,improved treatment responseAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
